Cargando…

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention

The purpose of this study was to summarize the clinical characteristics and risk factors of major adverse cardiovascular events (MACEs) in patients who had had acute myocardial infarction (AMI) within 1 year of percutaneous coronary intervention (PCI). A total of 421 AMI patients who were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Defeng, Xiao, Shengjue, Hu, Yue, Pan, Qinyuan, Wu, Qi, Wang, Xiaotong, Liu, Qiaozhi, Liu, Ailin, Liu, Jie, Zhu, Hong, Zhou, Yufei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687843/ https://www.ncbi.nlm.nih.gov/pubmed/34987604 http://dx.doi.org/10.1155/2021/3758320

Ejemplares similares

MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction
por: Xiao, Shengjue, et al.
Publicado: (2021)

Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Xiao, Shengjue, et al.
Publicado: (2021)

Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis
por: Xiao, Shengjue, et al.
Publicado: (2021)

Diagnostic value of parameters derived from planar MUGA for detecting HFpEF in coronary artery disease patients
por: Liu, Qiaozhi, et al.
Publicado: (2023)

Identification of Differentially Expressed Genes and Pathways in Human Atrial Fibrillation by Bioinformatics Analysis
por: Pan, Defeng, et al.
Publicado: (2022)

Novel grading system for ischemia‒reperfusion injury manifestations in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Wang, Xiaotong, et al.
Publicado: (2022)

Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year
por: Hu, Yue, et al.
Publicado: (2022)

Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3–5 chronic kidney disease
por: Hu, Yue, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting All-Cause Mortality in Patients with Hemodialysis Having Pulmonary Hypertension
por: Wu, Huimin, et al.
Publicado: (2023)

A Clinical Nomogram Based on the Triglyceride-Glucose Index to Predict Contrast-Induced Acute Kidney Injury after Percutaneous Intervention in Patients with Acute Coronary Syndrome with Diabetes Mellitus
por: Hu, Yue, et al.
Publicado: (2022)

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
por: Zhao, Enfa, et al.
Publicado: (2020)

Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery – A Meta-Analysis
por: Wang, Xiaotong, et al.
Publicado: (2023)

Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Roles of ST2, IL‐33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention
por: Wang, Yan‐Peng, et al.
Publicado: (2017)

Predictive nomogram model for major adverse kidney events within 30 days in sepsis patients with type 2 diabetes mellitus
por: Xin, Qi, et al.
Publicado: (2022)

Prevalence and association of medication nonadherence with major adverse cardiovascular events in patients with myocardial infarction
por: Hou, Yunfeng, et al.
Publicado: (2019)

Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
por: Zhao, Xiaoxiao, et al.
Publicado: (2022)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

The Impact of Admission Serum Creatinine on Major Adverse Clinical Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Vinod, Poornima, et al.
Publicado: (2018)

Association between serum hemoglobin and major cardiovascular adverse event in Chinese patients with ST‐segment elevation myocardial infarction after percutaneous coronary intervention
por: Yang, Yulu, et al.
Publicado: (2021)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention
por: Ying, Chen, et al.
Publicado: (2023)

Impact of Three-Dimensional Strain on Major Adverse Cardiovascular Events after Acute Myocardial Infarction Managed by Primary Percutaneous Coronary Intervention—A Pilot Study
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction
por: Shon, Ho Sun, et al.
Publicado: (2017)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
por: Chai, Qiaoying, et al.
Publicado: (2023)

Association Between Medication Adherence and 1‐Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China
por: Shang, Pu, et al.
Publicado: (2019)

Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
por: Zhao, Xiaoxiao, et al.
Publicado: (2020)

Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction
por: Guo, Wen, et al.
Publicado: (2023)

Combination of eosinophil percentage and high‐sensitivity C‐reactive protein predicts in‐hospital major adverse cardiac events in ST‐elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
por: Ye, Liu, et al.
Publicado: (2020)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
por: Sato, Jun, et al.
Publicado: (2023)

Analysis between high risk of myocardial infarction with non‐obstructive coronary artery disease in single center and occurrence of major adverse cardiovascular events
por: Kong, Meihong, et al.
Publicado: (2022)

Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study
por: Cheng, Yu-Tsung, et al.
Publicado: (2014)

Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2023)

Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
por: Wlazeł, Rafał N., et al.
Publicado: (2016)

Usefulness of serial post-systolic shortening by speckle tracking echocardiography to predict major adverse cardiovascular events and segmental function improvement after acute myocardial infarction
por: Hsiao, Ju-Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sovra162g1mdord1m1150eae42